Health system delay and risk factors in pulmonary tuberculosis diagnosis before and during the COVID-19 epidemic: a multi-center survey in China
In China, HSD in PTB diagnosis remains relatively low and is primarily mediated by factors associated with health providers. No significant impact on HSD from the COVID-19 epidemic has been found. Implementing targeted training programs to enhance health providers' awareness of chronic respiratory symptoms and maintain vigilance for PTB; strengthening presumptive PTB identification capabilities at grassroots health facilities, and promoting the use of <i>Mycobacterium tuberculosis</i> (MTB) bacteriological technologies are recommended to shorten the HSD.
Authors
- Canyou Zhang (ORCID: https://orcid.org/0000-0003-1819-5347)
- Hui Zhang (ORCID: https://orcid.org/0000-0002-6844-4375)
- Yuhong Li (ORCID: https://orcid.org/0000-0002-3544-4475)
- Kui Liu (ORCID: https://orcid.org/0000-0001-9833-1251)
- Ming Fan (ORCID: https://orcid.org/0000-0002-7384-5421)
- Yushu Liu (ORCID: https://orcid.org/0000-0001-6172-4094)
- Tao Li (ORCID: https://orcid.org/0000-0002-3176-018X)
- Jun Cheng (ORCID: https://orcid.org/0009-0004-9469-4134)
- Xiaoqiu Liu
Institutions
- Chinese Center For Disease Control and Prevention (CN)
- Zhejiang Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-02-26
- DOI
- https://doi.org/10.3389/fpubh.2025.1526774
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.40